ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 113 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,039 | -20.7% | 151,704 | +20.1% | 0.01% | +20.0% |
| Q2 2023 | $1,310 | +443.6% | 126,347 | +323.4% | 0.01% | +233.3% |
| Q1 2023 | $241 | +107.8% | 29,843 | +305.4% | 0.00% | +200.0% |
| Q4 2022 | $116 | -99.9% | 7,361 | -45.9% | 0.00% | -66.7% |
| Q3 2022 | $214,000 | +7.5% | 13,598 | -0.6% | 0.00% | +200.0% |
| Q4 2021 | $199,000 | -47.4% | 13,679 | -34.9% | 0.00% | -50.0% |
| Q3 2021 | $378,000 | +2600.0% | 21,012 | +58.2% | 0.00% | – |
| Q1 2020 | $14,000 | -96.6% | 13,280 | -4.9% | 0.00% | -100.0% |
| Q1 2017 | $417,000 | – | 13,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |